Biolargo, Inc. last reported quarterly results on Aug 14, 2018, for the quarter ended Jun 30, 2018. It usually reports 45 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 45 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 14, 2018
45 days after quarter end
|
—
ended Jun 30, 2018
|
—
|
—
|
—
|
Company profile
- Industry
- Chemicals & Allied Products (SIC 2800)
- Listed as
- BLGO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westminster, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 880242
- Former names
- NUWAY MEDICAL INC (until Apr 3, 2007); NUWAY ENERGY INC (until Feb 5, 2003); LATIN AMERICAN CASINOS INC (until Feb 15, 2001)
Other Chemicals & Allied Products companies
- Akzo Nobel NV AKZOY
- Solstice Advanced Materials Inc. SOLS
- Balchem Corp BCPC
- Perimeter Solutions, Inc. PRM
- Ingevity Corp NGVT
- Innospec Inc. IOSP
- Chemours Co CC
- OLIN Corp OLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.